Related Experiment Video
Updated: Jan 21, 2026

06:46
Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages
Published on: June 30, 2016
30.9K
Monocytes and macrophages in atherogenesis
Jaume Amengual1, Tessa J Barrett2
1Division of Nutritional Sciences, Department of Food Sciences and Human Nutrition, University of Illinois Urbana Champaign, Urbana, Illinois.
Current Opinion in Lipidology
|July 31, 2019
Summary
Monocytes and macrophages are crucial in atherosclerosis. Understanding their diverse subtypes and functions offers new therapeutic targets for cardiovascular disease, aiding plaque stabilization and growth control.
Area of Science:
- Cardiovascular Research
- Immunology
- Cell Biology
Background:
- Monocytes and macrophages are central to atherosclerosis development, influencing plaque growth and stability.
- The metabolic and phenotypic heterogeneity of myeloid cells is increasingly recognized.
- This review focuses on recent advancements in understanding these cell types in atherogenesis.
Purpose of the Study:
- To review current literature on monocyte and macrophage subsets in atherosclerosis.
- To highlight the contribution of distinct myeloid cell subtypes to atherogenesis.
- To explore the role of myelopoiesis mediators.
Main Methods:
- Literature review of recent studies on monocyte and macrophage biology.
- Analysis of phenotypic and metabolic characteristics of myeloid cell subsets.
- Synthesis of findings related to cardiovascular disease pathogenesis.
Main Results:
- Monocytes differentiate into diverse, long-lived macrophages in circulation.
- Specific monocyte and macrophage subtypes differentially impact plaque development.
- Novel characterizations of these subtypes and myelopoiesis mediators are emerging.
Conclusions:
- Understanding monocyte and macrophage phenotypes is key to developing new therapies.
- Targeting these cells may help manage atherosclerotic plaque growth and stability.
- Further research into myeloid cell regulators is essential for cardiovascular disease treatment.

